NIH-funded research R01 grant

Direct measurement of RhD sensitization after early-pregnancy bleeding

Official title: Direct Measurement of RhD Sensitization Following Bleeding in Pregnancy Less than 12 Weeks Gestation

Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11413670 · Data updated 2026-11-12

This study tests how often Rh immunoglobulin given after bleeding in early pregnancy prevents RhD sensitization in pregnant people.

More Pregnancy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr
NIH-funded
Lab location1 site (Hershey, United States)
Project startSeptember 10, 2025
Project endMay 31, 2030
Funding year2026
Award (this year)$658,136
NIH project number5R01HD116890-02
Project IDNIH-11413670 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people with bleeding before 12 weeks gestation who are candidates for RhIg management.

Less likely to help

Patients without bleeding before 12 weeks or those not considered for RhIg would not directly benefit from this specific measurement study.

What this research studies

RhIg is a scarce blood product used to prevent RhD sensitization. This project directly measures sensitization rates in pregnant individuals with bleeding before 12 weeks to clarify whether routine RhIg at this stage is needed. The researchers plan to enroll participants, track bleeding events, and determine sensitization outcomes, aiming to guide clearer, evidence-based use of RhIg. Results could influence guidelines and help conserve RhIg supplies while protecting mothers and babies.

Why it matters

Potential benefit: If successful, the study could refine when RhIg is truly necessary, reducing unnecessary use and preserving scarce RhIg for cases with clear benefit.

How similar studies have gone: Previous population studies have suggested limited benefit of early-RhIg, but direct measurement in this specific setting is novel and may confirm or refine those findings.

Where this research is happening

  • Pennsylvania State Univ Hershey Med Ctr
    Hershey, United States
    Active

Researchers

  • Principal investigator: Horvath, Sarah — Pennsylvania State Univ Hershey Med Ctr
  • Study coordinator: Horvath, Sarah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.